Cardiol Therapeutics raises $11 million to advance heart disease therapies
PositiveFinancial Markets

Cardiol Therapeutics has successfully raised $11 million to further develop its innovative therapies aimed at treating heart disease. This funding is crucial as it allows the company to advance its research and bring new treatment options to patients suffering from cardiovascular conditions. With heart disease being a leading cause of death globally, this investment not only supports the company's growth but also has the potential to significantly impact public health.
— Curated by the World Pulse Now AI Editorial System